Cargando…
Targeting RNA N(6)-methyladenosine modification: a precise weapon in overcoming tumor immune escape
Immunotherapy, especially immune checkpoint inhibitors (ICIs), has revolutionized the treatment of many types of cancer, particularly advanced-stage cancers. Nevertheless, although a subset of patients experiences dramatic and long-term disease regression in response to ICIs, most patients do not be...
Autores principales: | Li, Wei, Hao, Yi, Zhang, Xingda, Xu, Shouping, Pang, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454167/ https://www.ncbi.nlm.nih.gov/pubmed/36071523 http://dx.doi.org/10.1186/s12943-022-01652-3 |
Ejemplares similares
-
Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
por: Li, Wei, et al.
Publicado: (2021) -
Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy
por: Li, Hui, et al.
Publicado: (2021) -
The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022) -
Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021) -
N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022)